Dan Xu , Yanpeng Ci , Ying Hou , Le Yu , Jun Tian , Haozhe Ruan , Yina Shen , Jingjing Zhang , Huifen Yu , Hanyi Wang , Ming Zhang , Guangyao Hu , Muchen Li , Tianli Zhang , Yongsheng Xiao , Vadim Tsvetnitsky , Jun Luo , Sherry Gu , Weichang Zhou
{"title":"Developing a scalable framework for mitigating GEV and dissolved CO2 stresses in high-density CHO cell cultures","authors":"Dan Xu , Yanpeng Ci , Ying Hou , Le Yu , Jun Tian , Haozhe Ruan , Yina Shen , Jingjing Zhang , Huifen Yu , Hanyi Wang , Ming Zhang , Guangyao Hu , Muchen Li , Tianli Zhang , Yongsheng Xiao , Vadim Tsvetnitsky , Jun Luo , Sherry Gu , Weichang Zhou","doi":"10.1016/j.bej.2025.109851","DOIUrl":null,"url":null,"abstract":"<div><div>Intensified fed-batch featuring high-cell-density cultures highlights challenges in bioreactor scale-up and underscores the needs for tailored mitigation, particularly on the reconciliation of the hydrodynamic stress from sparger gas entrance velocity (GEV) and accumulated CO₂ partial pressure (pCO₂). In this study, elevated GEV and pCO₂ were identified as the causes of titer reduction during the scale-up to a 2000 L single-use bioreactor (SUB). To verify this hypothesis, a scaled-down model was established in bench-scale bioreactors equipped with a customized sparger to simulate the high GEV and pCO₂ conditions. The model reproduced the impaired titer performance, showing that both factors inhibited production through an independent mechanism and a culture phase-dependent manner. Proteomic analysis of the two stresses further revealed differentially protein expressions associated with cell proliferation, energy generation and reactive oxygen species induced cellular responses. Lastly, an optimized scale-up strategy balancing effective pCO<sub>2</sub> stripping with controlled GEV stress was implemented through a modified 2000 L SUB with an upgraded sparger design. This work elucidated the interplay between elevated pCO<sub>2</sub> and GEV stresses and culture performance, establishing a systematic framework for modulating GEV and pCO₂ as a universal scale-up tool. The findings advanced scale-up strategies for all mammalian cell cultures, especially for shear stress- and/or pCO₂-sensitive cell lines, while reinforcing mechanistic insights into bioprocess scalability for industrial applications.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"222 ","pages":"Article 109851"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25002256","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Intensified fed-batch featuring high-cell-density cultures highlights challenges in bioreactor scale-up and underscores the needs for tailored mitigation, particularly on the reconciliation of the hydrodynamic stress from sparger gas entrance velocity (GEV) and accumulated CO₂ partial pressure (pCO₂). In this study, elevated GEV and pCO₂ were identified as the causes of titer reduction during the scale-up to a 2000 L single-use bioreactor (SUB). To verify this hypothesis, a scaled-down model was established in bench-scale bioreactors equipped with a customized sparger to simulate the high GEV and pCO₂ conditions. The model reproduced the impaired titer performance, showing that both factors inhibited production through an independent mechanism and a culture phase-dependent manner. Proteomic analysis of the two stresses further revealed differentially protein expressions associated with cell proliferation, energy generation and reactive oxygen species induced cellular responses. Lastly, an optimized scale-up strategy balancing effective pCO2 stripping with controlled GEV stress was implemented through a modified 2000 L SUB with an upgraded sparger design. This work elucidated the interplay between elevated pCO2 and GEV stresses and culture performance, establishing a systematic framework for modulating GEV and pCO₂ as a universal scale-up tool. The findings advanced scale-up strategies for all mammalian cell cultures, especially for shear stress- and/or pCO₂-sensitive cell lines, while reinforcing mechanistic insights into bioprocess scalability for industrial applications.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.